Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus.
作者信息
Kim Hye Soon
机构信息
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
出版信息
Diabetes Metab J. 2024 Sep;48(5):882-884. doi: 10.4093/dmj.2024.0479. Epub 2024 Sep 1.
Abstract
摘要
相似文献
1
Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus.2型糖尿病患者口服降糖药的理想联合用药
Diabetes Metab J. 2024 Sep;48(5):882-884. doi: 10.4093/dmj.2024.0479. Epub 2024 Sep 1.
2
Metformin: a multitasking medication.二甲双胍：一种多功能药物。
Diab Vasc Dis Res. 2008 Sep;5(3):156. doi: 10.3132/dvdr.2008.026.
3
[Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].糖尿病胰岛素与口服降糖药联合治疗
Nihon Rinsho. 1990 Dec;48 Suppl:1031-7.
4
[American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success].[美国糖尿病协会年会：甘精胰岛素新数据：早期联合使用有望取得更大成功]
MMW Fortschr Med. 2005 Aug 18;147(33-34):44-5.
5
[New fast-acting insulin analog. This insulin profits type l and type 2 diabetics].新型速效胰岛素类似物。该胰岛素对1型和2型糖尿病患者有益。
MMW Fortschr Med. 2004 Nov 18;146(47):62-3.
6
7
[Treatment of diabetes mellitus: general goals, and clinical practice management].[糖尿病的治疗：总体目标及临床实践管理]
Rev Esp Cardiol. 2002 Aug;55(8):845-60. doi: 10.1016/s0300-8932(02)76714-6.
8
Saxagliptin (Onglyza) for type 2 diabetes.沙格列汀（安立泽）用于2型糖尿病。
Med Lett Drugs Ther. 2009 Nov 2;51(1324):85-6.
9
[Thus to avoid complications of diabetes. To combine early].因此，为避免糖尿病并发症。尽早联合使用。 （你提供的原文似乎不太完整和连贯，翻译可能会受一定影响，你可检查下原文是否准确）
MMW Fortschr Med. 2001 Nov 1;143(44):60.
10
Treating hyperglycemia in type 2 diabetes: new goals and strategies.治疗2型糖尿病中的高血糖：新目标与策略。
Cleve Clin J Med. 2002 Oct;69(10):809-20. doi: 10.3949/ccjm.69.10.809.
本文引用的文献
1
Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study.吡格列酮添加治疗对二甲双胍和达格列净控制不佳的 2 型糖尿病患者的疗效和安全性：一项多中心、随机、双盲、安慰剂对照研究。
Clin Ther. 2024 Sep;46(9):662-669. doi: 10.1016/j.clinthera.2024.06.023. Epub 2024 Jul 26.
2
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.吡格列酮联合钠-葡萄糖共转运蛋白 2 抑制剂或胰高血糖素样肽-1 受体激动剂对 2 型糖尿病结局的影响：一项来自国际联合数据库的系统评价、荟萃分析和真实世界研究。
Diabetes Obes Metab. 2024 Jul;26(7):2606-2623. doi: 10.1111/dom.15576. Epub 2024 Apr 1.
3
Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial.吡格列酮作为二甲双胍和达格列净控制不佳的 2 型糖尿病患者的附加治疗：双盲、随机、安慰剂对照试验。
Diabetes Metab J. 2024 Sep;48(5):937-948. doi: 10.4093/dmj.2023.0314. Epub 2024 Feb 2.
4
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.9. 血糖治疗的药物学方法：2024 年糖尿病护理标准。
Diabetes Care. 2024 Jan 1;47(Suppl 1):S158-S178. doi: 10.2337/dc24-S009.
5
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.2023 年韩国糖尿病协会糖尿病临床实践指南。
Diabetes Metab J. 2023 Sep;47(5):575-594. doi: 10.4093/dmj.2023.0282. Epub 2023 Sep 26.
6
Pioglitazone, SGLT2 inhibitors and their combination for primary prevention of cardiovascular disease and heart failure in type 2 diabetes: Real-world evidence from a nationwide cohort database.吡格列酮、SGLT2 抑制剂及其联合用于 2 型糖尿病的心血管疾病和心力衰竭的一级预防：来自全国队列数据库的真实世界证据。
Diabetes Res Clin Pract. 2023 Jun;200:110685. doi: 10.1016/j.diabres.2023.110685. Epub 2023 Apr 24.
7
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的共识报告：2 型糖尿病患者高血糖管理。
Diabetologia. 2022 Dec;65(12):1925-1966. doi: 10.1007/s00125-022-05787-2. Epub 2022 Sep 24.
8
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.班廷讲座。从三人组合到不祥八重奏：2型糖尿病治疗的新范式
Diabetes. 2009 Apr;58(4):773-95. doi: 10.2337/db09-9028.
9
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.2型糖尿病患者大血管事件的二级预防：PROactive研究（吡格列酮大血管事件前瞻性临床试验）：一项随机对照试验
Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9.
Zotero 插件